Drug or treatment

Befotertinib clinical trials

• 6Clinical trials
• 1Country

Newest trials

All recruiting trials (6)

• Befotertinib with Rifampicin or Itraconazole in Healthy People

  This study tests how Befotertinib behaves in the body when taken with rifampicin or itraconazole in healthy volunteers.

  Recruiting Phase 1 Betta Pharmaceuticals Co., Ltd. · Hangzhou, Zhejiang · NCT07809815

• Befotertinib plus chemo with MRD-guided escalation for EGFR-mutant NSCLC

  This phase 2 trial tests whether starting befotertinib and then using MRD results to guide adding chemotherapy improves outcomes for adults with EGFR-mutant advanced NSCLC.

  Recruiting Phase 2 Guangzhou University of Traditional Chinese Medicine · Guangzhou, Guangdong and 1 other locations · NCT07709585

• Sequential pemetrexed + carboplatin followed by befotertinib for EGFR‑mutant NSCLC after resistance to third‑generation EGFR inhibitors

  This treatment plan will see if giving pemetrexed plus carboplatin followed by the oral drug befotertinib helps people with EGFR‑mutant non‑small cell lung cancer who have stopped responding to third‑generation EGFR inhibitors.

  Recruiting at 2 sites Phase 2 Betta Pharmaceuticals Co., Ltd. · Guangzhou, Guangdong and 1 other locations · NCT07181499

• Evaluating befotertinib for advanced non-small cell lung cancer with specific EGFR mutations

  This study is testing a new drug called befotertinib to see if it can help people with advanced lung cancer who have specific types of EGFR mutations after other treatments haven't worked.

  Recruiting Phase 2 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT06863506

• Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment

  This study is testing if a new lung cancer treatment combining befotertinib with either bevacizumab or chemotherapy can help patients with early-stage cancer that has an EGFR mutation feel better before surgery.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06755684

• Befotertinib for treating early-stage non-small cell lung cancer with specific mutations

  This study is testing if a new drug called Befotertinib can help people with early-stage non-small cell lung cancer and specific mutations feel better after surgery compared to an existing treatment.

  Recruiting at 3 sites Phase 3 Betta Pharmaceuticals Co., Ltd. · Beijing and 2 other locations · NCT06041776

Quick answers

How many clinical trials of Befotertinib are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →